Innovation Pharmaceuticals Inc (IPIX)

[Chronic]

Thanks for all the analysis TradingPro. The data looks pretty good. My only concern with the KM graph is it's only looking at the 39 "per protocol" patients. There were another 22 patients in the trial. I think it's fair to drop the 15 patients who didn't receive at least 55Gy radiation. However, why did those drop out and for what reason? Did they develop SOM even though they didn't receive 55Gy? It would be great to have those answers, but overall the data looks good and I'm sure it's enough to get a deal done in 2018.